AGI-134
AGI-134 is a synthetic alpha-Gal glycolipid that activates CD8+ T cell-mediated immunity, leading to targeted tumor cell lysis and phagocytosis. This mechanism supports its research application in studying immunotherapeutic strategies against cancer in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1821461-84-0
Smiles
O ([C@@H]1[C@@H] (CO) O[C@@H] (OCCCNC (CCCCC (NCCOP (OC[C@H] (OC (CCCCCCC/C=C\CCCCCCCC) =O) COC (CCCCCCC/C=C\CCCCCCCC) =O) (=O) O) =O) =O) [C@H] (NC (C) =O) [C@H]1O) [C@H]2[C@H] (O) [C@@H] (O[C@H]3O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H]3O) [C@@H] (O) [C@@H] (CO) O2
Molecular Formula
C70H126N3O26P
Molecular Weight
1456.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15218858 1 Vial
Lentiviral mouse Ptx4 shRNA (UAS) - Lentiviral mouse Ptx4 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
GTR15356158 1 Vial
Lentiviral human FSTL1 sgRNA gene knockout kit - Lentiviral human FSTL1 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details